Literature DB >> 29594240

Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication.

Nafisha Lalani1, Shao Hui Huang1, Coleman Rotstein2, Eugene Yu3, Jonathan Irish4, Brian O'Sullivan1.   

Abstract

Osteomyelitis, infection of the bone and marrow, following high dose (chemo-)radiotherapy for head and neck cancer is uncommon and rarely seen in the cervical spine or temporal bone. Due to its proximity to critical structures, osteomyelitis in the latter regions could carry potentially important consequences. Furthermore, involvement near the skull base (e.g. temporal bone and high cervical vertebrae) presents unique challenges in diagnosis (especially in the differentiation from disease recurrence) and treatment, making early detection and timely intervention critical. In this report, we describe two cases of osteomyelitis, one involving the temporal bone and the other affecting the 2nd and 3rd cervical vertebrae, diagnosed and treated with good outcome in the setting of definitive chemoradiotherapy for locally advanced pharyngeal carcinomas. We suggest that for new or evolving post-radiotherapy osseous changes in regions that have received a high dose of radiotherapy, associated with unexpected and deteriorating spinal symptoms such as pain and spasm, radiation-related osteomyelitis should be considered in the differential diagnosis from tumor progression. Timely referral to a surgical oncologist and infectious diseases specialist is paramount in achieving satisfactory clinical outcomes.

Entities:  

Keywords:  Bone; Chemoradiotherapy; Head and neck cancer; Osteomyelitis

Year:  2017        PMID: 29594240      PMCID: PMC5862672          DOI: 10.1016/j.ctro.2017.11.005

Source DB:  PubMed          Journal:  Clin Transl Radiat Oncol        ISSN: 2405-6308


Introduction

The treatment of locally advanced head and neck malignancies usually entails radical radiotherapy augmented by concurrent chemotherapy [1], [2], [3], [4]. This approach permits organ preservation as an alternative to surgery in many advanced oropharyngeal cancers, or curative treatment for nasopharyngeal carcinoma where surgery is not ordinarily employed due to anatomic considerations. Unfortunately, the sequelae of radiation treatment often include stromal and vascular fibrosis with subsequent decreases in microcirculation [5]. The clinic-pathologic result of these changes may include delayed mucosal healing within the irradiated volume. In turn, persistent mucosal breakdown can serve as both a nidus and a portal of entry for infection due to loss of mucosal barrier function and compromised vascular supply [6]. Following active cancer treatment, patients generally undergo long-term surveillance. Post-radiotherapy radiographic changes in osseous and non-osseous tissues may occur for several reasons including radiotherapy-induced inflammation, fibrosis, osteonecrosis or disease recurrence. In this report, we present an additional entity that should be considered in the differential diagnoses of evolving symptomatic radiologic bone abnormalities. We describe two cases of osteomyelitis, one involving the temporal bone and the other affecting the 2nd and 3rd cervical vertebrae (C2–C3), diagnosed and treated with good outcome in the setting of definitive chemoradiotherapy (CRT) for locally advanced pharyngeal carcinomas.

Case 1

A 54-year-old male current smoker with a 40-pack year smoking history, peripheral vascular disease and polycythemia requiring repeated phlebotomies presented with a 6-week history of sore throat caused by an infiltrating lesion in the right posterior pharyngeal wall. The lesion involved the right posterior tonsillar pillar and soft palate with extension across the midline, and with posterior thickening at the junction of the oropharynx and hypopharynx measuring 6.4 cm in craniocaudal dimension. Biopsy confirmed a high-grade p16 negative mucosal squamous cell carcinoma. An associated 1.3 cm necrotic retropharyngeal node was also evident on magnetic resonance imaging (MRI). The disease was staged as a T3N1M0 posterior pharyngeal wall HPV-negative oropharyngeal carcinoma and the patient was offered definitive concurrent CRT (IMRT 70 Gy in 35 fractions [Fig. 1A] and elective bilateral neck irradiation (not shown in the figure) with concurrent high-dose cisplatin [100 mg/m2] on weeks 1, 4, and 7). However, he developed ototoxicity after one cycle of chemotherapy and an acute lower extremity vascular occlusion after 26 Gy of radiotherapy. His right lower extremity abruptly became cold and pulseless and a Doppler ultrasound demonstrated external iliac artery occlusion extending into proximal common femoral artery pelvic vessels that was managed without surgical intervention. For these reasons, his chemotherapy was discontinued but radiotherapy continued to a full dose of 70 Gy without interruption.
Fig. 1

Sagittal view of radiotherapy planning computerized tomography (A) depicting the original gross tumor volume (colour wash) and 70 Gy isodose line encompassing the anterior components of C2–C3 vertebral bodies where osteomyelitis occurred. Sagittal (B) and axial (C) fat-saturated T2-weighted magnetic resonance images show evolving tumor ulceration along the posterior oropharyngeal wall (arrows).

Sagittal view of radiotherapy planning computerized tomography (A) depicting the original gross tumor volume (colour wash) and 70 Gy isodose line encompassing the anterior components of C2–C3 vertebral bodies where osteomyelitis occurred. Sagittal (B) and axial (C) fat-saturated T2-weighted magnetic resonance images show evolving tumor ulceration along the posterior oropharyngeal wall (arrows). After completion of radiotherapy, the patient had a good response to treatment on imaging. although, a flexible nasopharyngoscopy showed a persisting area of ulceration along the posterior pharyngeal wall mucosa [Fig. 1B and C]. Biopsy by an experienced head and neck surgical oncologist (JI) confirmed that there was no residual carcinoma. Continued monitoring of the area showed persistent but improving ulceration, and he was instructed frequently about smoking cessation which remained a challenge for him. Two years after completion of radiotherapy, he developed acute onset bilateral neck pain, radiating to the occipital area. Examination revealed that the mucosal ulcer appeared deeper and was associated with a mild foetor. A repeat biopsy of the area of ulceration revealed no evidence of malignancy. A bone scan showed no uptake in the cervical spine. MRI showed a slight increase in the extent of ulceration as well as new abnormal signal changes in the C2 and C3 vertebral bodies [Fig. 2A]. However, no signs of septicemia or neurological compromise were evident. A repeat MRI performed after three months showed further progression of the ulcerated area as well as increased marrow abnormalities in the cervical spine with development of an epidural collection abutting the anterior margin of the spinal cord [Fig. 2B–D].
Fig. 2

Magnetic Resonance Image (MRI) demonstrates edema in the C2–C3 vertebrae with intact endplate margins (A). Loss of disc space height between C2 and C3 with endplate irregularity is evident and mild pressure on the subarachnoid space from an anterior epidural phlegmon has developed 3 months later (B). Enhancing epidural phlegmon (long arrow) is also evident in the anterior epidural space (C) and epidural phlegmon surrounding the vertebral arteries (short arrows) (D). The findings are typical of a discitis-osteomyelitis complex.

Magnetic Resonance Image (MRI) demonstrates edema in the C2–C3 vertebrae with intact endplate margins (A). Loss of disc space height between C2 and C3 with endplate irregularity is evident and mild pressure on the subarachnoid space from an anterior epidural phlegmon has developed 3 months later (B). Enhancing epidural phlegmon (long arrow) is also evident in the anterior epidural space (C) and epidural phlegmon surrounding the vertebral arteries (short arrows) (D). The findings are typical of a discitis-osteomyelitis complex. Although cancer recurrence was again considered, the findings were more consistent with a probable discitis complicated by an epidural abscess, likely introduced through the ulcerated mucosa. The case was thought to be too risky for surgical drainage following neurosurgical consultation. After assessment by an infectious disease specialist (CR) a decision was made that the patient should be started on high dose IV antimicrobial therapy for osteomyelitis. Initially this involved amoxicillin/clavulanic acid for a period of one week and then switched to intravenous piperacillin/tazobactam 4.5 grams every 8 h for an additional 8 weeks once a peripherally inserted central catheter was placed. Within 2 weeks of commencing antibiotic therapy, there was significant improvement in neck pain and stiffness, with complete resolution of symptoms after completion of antimicrobial therapy. Simultaneously, the posterior pharyngeal mucosal ulceration started to improve within 2 weeks, and was documented to be completely healed 2 months following completion of a 77-day course of antimicrobial therapy. The patient remains disease-free without other late sequelae 10 years following his original head and neck cancer treatment.

Case 2

A 53-year-old non-smoking Asian female with a two-year history of a right neck mass associated with nasal obstruction and epistaxis presented with severe temporal headache and marked diplopia. On clinical examination, the patient had a right-sided upper-lid ptosis with complete eye closure, trismus, and unilateral cranial nerve three, six, and twelve nerve palsies. Flexible nasopharyngoscopy revealed a large nasopharyngeal mass. Subsequent biopsies of the lesion and right neck node confirmed a nonkeratinizing carcinoma of undifferentiated type, positive for Epstein-Barr virus-encoded RNA (EBER). Plasma Epstein-Barr viral (EBV) load by PCR was elevated (1627 copies per ml). MRI and positron emission tomography (PET) imaging revealed an extensive nasopharyngeal mass involving the entire nasopharynx with extension through the foramen ovale and foramen lacerum into the right cavernous sinus juxtaposed to the pituitary gland [Fig. 3A and B]. The bony central skull base was extensively replaced by tumor. Bilateral enlarged lymph nodes were evident, the largest of which was 2.5 cm in the right level 2 region. The disease was staged as a T4N2 nasopharyngeal carcinoma with extensive encroachment adjacent to critical skull base anatomy that included cranial nerves, the optic apparatus, and the brain stem. The patient was treated with a course of high-dose concurrent CRT consisting of 70 Gy in 35 fractions to all gross disease [Fig. 3C] and elective radiotherapy to adjacent tissues and both necks (not shown in figure), delivered with concurrent cisplatin (100 mg/m2 on weeks 1, 4, and 7) and adjuvant cisplatin and 5-fluourouracil for 3 cycles. The disease responded successfully with recovery of cranial nerve findings and resolution of the EBV titres on all subsequent assays.
Fig. 3

Axial (A) and Coronal (B) MRI imaging shows nasopharyngeal carcinoma with extension into the right cavernous sinus, juxtaposed to the pituitary gland. The region of osteomyelitis was encompassed in the 66 Gy (inner thin line) radiotherapy volume (C).

Axial (A) and Coronal (B) MRI imaging shows nasopharyngeal carcinoma with extension into the right cavernous sinus, juxtaposed to the pituitary gland. The region of osteomyelitis was encompassed in the 66 Gy (inner thin line) radiotherapy volume (C). Five months after completion of concurrent CRT, the patient presented with rapidly progressive right-sided otitis externa, facial pain and restricted neck flexion with torticollis. Clinical examination showed an edematous auditory canal with no osseous exposure. Necrotic debris was evident throughout the nasopharynx without obvious signs of recurrence on flexible nasopharyngoscopy. Repeat EBV titres were performed to rule out recurrent disease and remained undetectable. MRI revealed diffuse swelling and enhancement involving bilateral petrous apices and the right masticator space with extension into the right external auditory canal that had received at least 66 Gy radiotherapy dose. Mild enhancement and edema was also seen in the left nasopharynx. [Fig. 4A–C]. The radiographic findings were compatible with acute inflammation with superimposed right necrotizing external otitis. A three-phase bone scan and indium white blood cell scan revealed focal leukocytic activity involving the masticator space and right aspect of the skull base in keeping with a diagnosis of osteomyelitis [Fig. 4D]. Due to the perilous location of her lesion, tissue diagnosis was not obtained; moreover the radiological assessment was more consistent with an underlying infectious process.
Fig. 4

Follow up contrast enhanced axial T1 weighted (A and B) and fat-saturated axial T2 weighted image (C) shows diffuse enhancement of the right external auditory canal and right masticator space. There is tissue ulceration and necrosis in the right posterolateral nasopharynx (white arrow). The T2 image shows a preservation of the tissue planes in the right masticator space supporting an inflammatory process rather than tumor infiltration. An indium-111 white blood cell scan (D) shows uptake in the region of the right masticator space, nasopharynx and right central bony skull base. These findings also favor an infectious process.

Follow up contrast enhanced axial T1 weighted (A and B) and fat-saturated axial T2 weighted image (C) shows diffuse enhancement of the right external auditory canal and right masticator space. There is tissue ulceration and necrosis in the right posterolateral nasopharynx (white arrow). The T2 image shows a preservation of the tissue planes in the right masticator space supporting an inflammatory process rather than tumor infiltration. An indium-111 white blood cell scan (D) shows uptake in the region of the right masticator space, nasopharynx and right central bony skull base. These findings also favor an infectious process. The patient was assessed by the same infectious disease specialist (CR) who had managed Case 1 and started on a course of empiric amoxicillin/clavulanate 875/125 mg BID for 10 weeks. After initiation of antimicrobial therapy, symptoms started resolving within 1 week and completely disappeared within several weeks. She remains symptom-free and disease-free in follow-up, with more than 3 years since completion of her antimicrobial treatment for her deep-seated skull base infection. No signs of disease are apparent and all cranial nerve deficits have resolved completely with complete return of ocular muscle function, eye opening, and return of function of the previously paralysed right tongue.

Discussion

Osteomyelitis, an infectious process of osseous structures (bone and marrow) is often associated with bony destruction [7]. It is a different bone entity from osteoradionecrosis (ischemic necrosis of the irradiated bone) albeit sharing somewhat similar signs and symptoms. While osteoradionecrosis is often chronic, osteomyelitis has a predisposition to acute sequelae requiring urgent intervention. This clinical entity was initially described in the writings of Hippocrates in 5th century BC and later termed “osteomyelitis” by Parisian surgeon Auguste Nélaton in 1844 [8]. Vertebral osteomyelitis, also referred to as pyogenic spondylitis, often entails the involvement of two endplates of adjacent vertebra due to the vascular anatomy of this region. The pathogenesis of osteomyelitis and in particular, vertebral osteomyelitis, may be precipitated by haematogenous seeding from a distant infected area, direct inoculation from trauma or invasive procedures, or contiguous spread from an adjacent area of infection [9]. Radiation could also predispose patient to osteomyelitis due to radiation-induced stromal and vascular fibrosis resulting in increased risk of bacterial or candida colonization and infection on the adjacent mucosal membrane [10]. Treatment varies from non-invasive (e.g. antimicrobial therapy, hyperbaric oxygen therapy) to invasive surgical interventions. The two cases included in this report are likely a consequence of ulceration in the adjacent mucosa that provides an entry portal for infection into the bone marrow and surrounding tissues juxtaposed to bone and/or intervertebral disc spaces. Thus, one might consider surgical closure as an option to prevent further progression to osteomyelitis. While local flap reconstruction can be considered in this situation, most experienced oncological and reconstructive surgeons recognize that local flap viability in a high dose radiation field is unreliable and may carry substantial risk of new wound healing problems. An additional issue is concern about potential persisting disease where early recurrence could be camouflaged by well-intended but putative approaches to repair residual post-radiotherapy ulceration that generally resolves with conservative management. Guidelines supporting a prophylactic surgical approach in this setting are unavailable. For this reason, close clinical surveillance was pursued in these two cases. Osteomyelitis in the head and neck region is rare and mostly occurs in the mandible, and only rarely in the cervical spine or temporal bone [11]. Due to its proximity to intracranial critical structures, osteomyelitis in the skull base region could carry potentially lethal consequences. For example, in the area of skull base, vascular complications such as mycotic aneurysm, infectious arteritis or arterial rupture in association with bony infection represent a realistic risk, especially to the intra-petrous and parapharyngeal internal carotid artery. Paralysis (25% rate overall, highest in cervical vertebrae) and death (11%) have also been reported in cases of vertebral osteomyelitis [12]. Radiation-induced osteomyelitis near the skull base region (temporal bone and C2–C3 cervical vertebrae) presents unique challenges in diagnosis and treatment. Early detection and timely intervention is critical. For acute osteomyelitis, initiating a course of antimicrobial therapy urgently is paramount to avoid severe detrimental outcomes [12]. Diagnosis of osteomyelitis in some head and neck cancer patients is challenging due to limitations in anatomic accessibility to obtain a tissue diagnosis to rule out possible disease recurrence. Surgical intervention would also be undesirable in this region due to anatomical constraints. A relatively sudden onset of deep intense pain associated with suggestions of inflammation such as spasm and edema should trigger suspicion and investigation. Radiological assessment by an experienced oncologic head and neck neuroradiologist with MRI is the most sensitive and non-invasive method for the diagnosis of osteomyelitis [13]. Common imaging characteristics include decreased signal intensity in the vertebral bodies and disc, and loss of endplate definition on T1-weighted images; increased disc and/or osseous signal intensity on T2-weighted images; and contrast enhancement of the bone. These characteristics were seen in both cases in this report, enabling prompt and accurate diagnosis of a potentially life-threatening infection. In vitro labeled leukocyte imaging performed with indium-111 tagged leukocytes was utilised for the second patient and may further aid in diagnosis. This modality provides improved specificity in comparison to bone scan but does not visualize osseous detail or differentiate between soft tissue infections and osteomyelitis [14]. A tissue diagnosis or microbial aspiration for cultures is preferred to ensure accurate diagnosis and appropriate pathogen-directed antimicrobial therapy. However, the complicated anatomy of the head and neck often makes instrumentation in this area precarious. Microbial cultures were not obtained in either of the presented cases due to the potential risks associated with procedures of the upper cervical spine and base of skull, and the risk of infection. In such instances, empiric antimicrobial therapy directed at potential pathogens should be initiated by an infectious disease specialist [9]. Our cases were treated in this manner leading to good outcomes in both instances and with eradication of the infectious process at subsequent prolonged follow up. Additional approaches dealing with chronic radiation injury that might be considered include hyperbaric oxygen and vasoactive agents (e.g. pentoxifylline) combined with anti-oxidants (e.g. tocopherol) [15], but were neither employed nor necessary in these two cases. However, if utilized, such approaches should not undermine the need for urgent and appropriate antimicrobial therapy to address established osteomyelitis. A high degree of vigilance is required to diagnose osteomyelitis in patients with malignant disease due to potential masking of clinical and radiological signs by treatment or cancer-related sequelae. In particular, care must be taken to distinguish this rare clinical entity from recurrent disease, as provision of anticancer therapies in the setting of osteomyelitis may intensify the infectious process and would be contraindicated. Patients who develop head and neck malignancies secondary to heavy smoking may also have significant peripheral vascular disease which may further contribute to a reduction in local tissue circulation leading to vascular insufficiency as was evident in Case 1. Moreover, the proximity of the irradiated bone and soft tissues to surrounding anatomical structures such as inflamed and infected pharyngeal, mastoid and paranasal sinuses, and nasal tissues provide potential portals of infection. In addition, continued tobacco use has been associated with increased incidence of grade 3–4 late toxicity, especially fibrosis following chemoradiation [16].

Conclusions

Osteomyelitis is a rare but potentially life-threatening condition in certain anatomic regions of head and neck which should be considered in the differential diagnosis of new or evolving post-radiotherapy osseous changes, particularly when changes are seen in regions juxtaposed to bone with potential portals for infection such as persistent mucosal ulceration following high dose (chemo-)radiotherapy. A high index of suspicion must be maintained for such cases and timely referral to a surgical oncologist and infectious diseases specialist, for prolonged intravenous antibiotics, is paramount in achieving satisfactory clinical outcomes. Further, optimization of baseline health status and promotion of smoking cessation should be initiated in all patients. Failure to identify and properly treat this entity would be expected to result in severe consequences.

Funding

None.

Conflict of interest

None.
  15 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

Review 2.  Effects of radiation on normal tissue: consequences and mechanisms.

Authors:  Helen B Stone; C Norman Coleman; Mitchell S Anscher; William H McBride
Journal:  Lancet Oncol       Date:  2003-09       Impact factor: 41.316

Review 3.  Oral complications of radiotherapy.

Authors:  James J Sciubba; David Goldenberg
Journal:  Lancet Oncol       Date:  2006-02       Impact factor: 41.316

4.  Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome.

Authors:  Allen M Chen; Leon M Chen; Andrew Vaughan; Radhika Sreeraman; D Gregory Farwell; Quang Luu; Derick H Lau; Kerri Stuart; James A Purdy; Srinivasan Vijayakumar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-14       Impact factor: 7.038

5.  Hyperbaric oxygen management of chronic staphylococcal osteomyelitis of the temporal bone.

Authors:  V G Schweitzer
Journal:  Am J Otol       Date:  1990-09

6.  Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals.

Authors:  Martin C McHenry; Kirk A Easley; Geri A Locker
Journal:  Clin Infect Dis       Date:  2002-04-22       Impact factor: 9.079

7.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Emilie Maillard; Jean Bourhis
Journal:  Radiother Oncol       Date:  2009-05-14       Impact factor: 6.280

8.  Osteomyelitis in the head and neck.

Authors:  Kishore Chandra Prasad; Sampath Chandra Prasad; Neela Mouli; Salil Agarwal
Journal:  Acta Otolaryngol       Date:  2007-02       Impact factor: 1.494

9.  Technetium bone scanning in the diagnosis of osteomyelitis: a meta-analysis of test performance. Diagnostic Technology Assessment Consortium.

Authors:  B Littenberg; A I Mushlin
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

Review 10.  Spinal infections: diagnostic tests and imaging studies.

Authors:  Howard S An; J Alex Seldomridge
Journal:  Clin Orthop Relat Res       Date:  2006-03       Impact factor: 4.176

View more
  1 in total

1.  Skull base osteomyelitis in patients with head and neck cancer: Diagnosis, management, and outcomes in a case series of 23 patients.

Authors:  Mary M Czech; Peter H Hwang; Alexander Dimitrios Colevas; Nancy Fischbein; Dora Y Ho
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.